EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations

Indranil Singh, Daniel Fernandez-Perez, Pedro Sanchez Sanchez, Alejo E Rodriguez-Fraticelli

Cell Stem Cell · 2025-04 · 32 (4) · 564-580.e6

DOI: 10.1016/j.stem.2025.01.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2025-04. Verfasst von Indranil Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain; Facultat de Bi…. Hauptthemen laut MEDLINE: Mutation, Neoplastic Stem Cells, Leukemia, Genetic Heterogeneity. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, Agència de Gestió d'Ajuts Universitaris i de Recerca, Caixabank SA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationNeoplastic Stem CellsLeukemiaGenetic HeterogeneityStem CellsAnimalsNucleophosminMiceHumansDNA Methyltransferase 3AClone CellsDNA (Cytosine-5-)-MethyltransferasesCell DifferentiationCell LineageNuclear Proteins

Stichwörter der Autor:innen

Dnmt3aNpm1cancer initiationcell barcodingcell of originclonal hematopoiesislineage tracingmyeloid leukemiamyeloid malignanciessingle-cell

Substanzen

NucleophosminDNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesNpm1 protein, mouseDnmt3a protein, mouseNuclear Proteins

Autor:innen und Institutionen

  • Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain; Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.
  • Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain; ICREA, Catalan Institution for Research and Advanced Studies Barcelona, Barcelona, C…

Förderung

  • Horizon 2020
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Caixabank SA
  • EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
  • Generalitat de Catalunya
  • Institut Ruđer Bošković
  • Universitat de Barcelona
  • Institució Catalana de Recerca i Estudis Avançats

Zitieren

APA

Singh, I., Fernandez-Perez, D., Sanchez, P. S., & Rodriguez-Fraticelli, A. E. (2025). Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations. Cell Stem Cell, 32(4), 564-580.e6. https://doi.org/10.1016/j.stem.2025.01.012

Vancouver

Singh I, Fernandez-Perez D, Sanchez PS, Rodriguez-Fraticelli AE. Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations. Cell Stem Cell. 2025;32(4):564-580.e6. doi:10.1016/j.stem.2025.01.012

BibTeX
@article{Singh2025,
  author = {Singh, Indranil and Fernandez-Perez, Daniel and Sanchez, Pedro Sanchez and Rodriguez-Fraticelli, Alejo E},
  title = {Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations},
  journal = {Cell Stem Cell},
  year = {2025},
  volume = {32},
  number = {4},
  pages = {564--580.e6},
  doi = {10.1016/j.stem.2025.01.012}
}
Kostenlos starten →